| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |